Introduction. Amniotic fluid lactate research is based on the hypothesis that a relationship exists between fatigued uterine muscles and raised concentrations of the metabolite lactate, which is excreted into the amniotic fluid during labor. To assess potentially confounding effects of lactate-producing organisms on amniotic fluid lactate measurements, we aimed to determine if the presence of vaginal Lactobacillus species was associated with elevated levels of amniotic fluid lactate, measured from the vaginal tract of women in labor. Material and methods. Results from this study contribute to a large prospective longitudinal study of amniotic fluid lactate at a teaching hospital in Sydney, Australia. Amniotic fluid lactate measurement was assessed at the time of routine vaginal examination, after membranes had ruptured, using a hand-held lactate meter StatStripXPress (Nova Biomedical). Vaginal swab samples were collected at the time of the first amniotic fluid lactate measurement and stored for later detection and quantification of Lactobacillus species using a TaqMan real-time PCR assay. Swab sample and amniotic fluid lactate results were paired and analyzed. Results. The PCR assay detected Lactobacillus species in 48 of 388 (12%) vaginal swab specimens (8% positive, 4% low positive) collected from women in labor after membranes had ruptured. There was no significant difference in median and mean (respectively) amniotic fluid lactate levels with (8.35 mmol/L; 8.95 mmol/L) or without (8.5 mmol/L; 9.08 mmol/L) Lactobacillus species detected. Conclusion. There was no association between the presence or level of vaginal Lactobacillus species and the measurement of amniotic fluid lactate collected from the vaginal tract of women during labor.
Introduction
Recent clinical studies of amniotic fluid lactate suggest that high amniotic fluid levels are associated with both labor dystocia (1-3) and adverse fetal outcomes (4) (5) (6) . In studies of amniotic fluid lactate, the authors hypothesize that irregular and long-standing myometrial contractions lead to myometrial tissue hypoxia with a decreased placental blood flow over time, resulting in an increase in the risk of hypoxia for the fetus (5) . Given that the myometrium is shown to be a producer of lactate during the ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 96 (2017) 487-495 first stage of labor (7) and that human myometrial cells deliver lactate to the extracellular medium under both anaerobic and aerobic conditions, it is proposed that lactate produced by the myometrium has a potential role in the underlying pathology of dysfunctional labor (8) . Although the fetus is recognized as a producer of lactate, and fetal scalp lactate is a useful indicator of intrapartum fetal distress, there is minimal evidence to show what proportion of lactate in amniotic fluid is of fetal or myometrial origin, or that lactate in fetal scalp blood is associated with high amniotic fluid lactate levels (5) .
At present, conclusions about the clinical utility of amniotic fluid lactate as a biomarker in labor are partly limited by the methods of sampling and analysis, and lack of knowledge of potential confounders. For example, researchers in the early studies of amniotic fluid lactate have collected samples using intrauterine catheters (3) . More recent studies have applied less invasive methods, collecting samples of freely flowing amniotic fluid from the glove of the examining clinician during vaginal examination (1) . There has been limited information published on the potential confounders of lactate measurement in amniotic fluid lactate (2, 5, 9, 10) . We hypothesized that Lactobacillus spp., the facultative, anaerobic and microaerophilic bacterium that convert lactose to lactic acid, have the potential to confound amniotic fluid lactate measurements, when collected from the vaginal tract during labor.
The aim of this study was to determine if among women in labor, naturally occurring vaginal Lactobacillus spp. produced sufficient lactate to confound amniotic fluid lactate results collected from the vaginal tract during labor. The results from this experiment contribute to a large prospective longitudinal study measuring the concentration of amniotic fluid lactate in the vaginal tract of women in labor (The Amniotic Fluid Lactate Project).
Material and methods
The study protocol for the Amniotic Fluid Lactate Project was approved by the New South Wales Northern Network Human Research Ethics Committee 11/140 through the National Ethics Application Submission AU/ 19E1A08.
Women eligible to be recruited to the Amniotic Fluid Lactate Research Project were nulliparous, with a singleton term pregnancy (>37 weeks) in a cephalic presentation and planning a vaginal birth at the study site, the Royal Hospital for Women, Sydney, Australia (Table 1) . A study database contained consenting participant's demographic, clinical and obstetric information, as well as details of amniotic fluid lactate results and vaginal swab collection. Women were included in the current study (The Lactobacillus Study) if they had a vaginal swab and a corresponding valid vaginal amniotic fluid lactate result recorded at the time of swab collection, after rupture of membranes.
Amniotic fluid lactate and swab sample collection
Between June 2013 and October 2015, on admission to the labor ward, eligible women were invited to participate in the study by the attending midwife, doctor or research midwife. Vaginal amniotic fluid lactate samples were collected: on admission if membranes had already ruptured, or at the time of spontaneous rupture, or when artificial rupture of membranes was performed for the purpose of induction or augmentation of labor. Amniotic fluid lactate was measured at the bedside using a handheld lactate meter (StatStripXPress; Nova Biomedical, Runcorn, UK), validated to measure lactate in amniotic fluid (10) . Further vaginal amniotic fluid lactate samples were collected at the time of routine vaginal examinations during the course of labor.
Vaginal swabs (Transystem Sterile Transport Swab; Copan, Murrieta, CA, USA) were collected from the mid vaginal cavity after membranes had ruptured either by the examining clinician at the time of vaginal examination, or self-collected by the woman in labor, according to the woman's preference. Swabs were placed in a refrigerator for up to 24 h before being stored at À80°C. Swabs (n = 388) with a valid corresponding vaginal amniotic fluid lactate result, recorded at the first vaginal examination in labor after membrane rupture, were selected and removed from the À80°C freezer for analysis. Total nucleic acid was extracted in batch sizes ranging from 30 to 55 swabs per Kingfisher run during July 2014 to November 2015. All samples were tested to show they were positive for the human housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (11) .
Nucleic acid extraction
Total nucleic acid was extracted by the MagNA Pure LC total nucleic isolation kit (03 038 505 001; Roche Diagnostics Australia, North Ryde, NSW, Australia) and KingFisher Flex Magnetic Particle Processor (Thermo Scientific, Waltham, MA, USA) as per the manufacturers' protocols. Swabs were thawed from À80°C to room temperature and the cotton tips were transferred into 2-mL sterile tubes containing 500 lL of viral maintenance media (VMM). The VMM consisted of medium 199 (11150-059; Gibco, ThermoFisher Scientific Pty Ltd, Scoresby, Vic, Australia) supplemented with 10% fetal bovine serum, 1.4% NaHCO 3 and gentamicin (40 mg/1 mL). Each tube containing the cotton tip and VMM was vortexed for 30 sec and 200 lL was immediately used for automated magnetic separation to a final volume of 100 lL in elution buffer; the remaining VMM mixture was stored at À80°C for future use. One negative process control using 200 lL of VMM only was included during each extraction run. Freeze-thawing of total nucleic acid was minimized by preparing each sample in three separate aliquots and storing them at À80°C until use.
Real-time TaqMan assay
The sequences for the PCR primers and probe for the TaqMan assay were selected from a published study targeting a 92-bp region of the 16S-23S intergenic spacer rRNA gene of 22 different Lactobacillus spp. (12) . The probe was synthesized by Applied BioSystems (Life Technologies, Pleasanton, CA, USA) with a VIC reporter molecule attached to the 5 0 end and an MGB-nonfluorescent quencher linked at the 3 0 end. The primers were synthesized by Sigma-Aldrich (Castle Hill, NSW, Australia). The PCR amplification was performed in a 25-lL volume containing 29 SensiMix™ II Probe reagent, which includes MgCl 2 (3 mmol/L final concentration) (BIO-91005, Bioline, Eveleigh, Australia), optimized concentrations of primers (200 nmol/L final concentration) and probe (75 nmol/L final concentration) and 5 lL of template. After preparation of the reaction plate, the whole plate was centrifuged at 1000 g for 1 min at room temperature in a swingout rotor (Microcentrifuge 5416, Eppendorf â ) to remove small air bubbles. The amplification and detection were performed in a Stratagene Mx3000P qPCR System (Agilent Technologies, Santa Clara, CA, USA) with the following conditions: (i) hot start 10 min at 95°C, (ii) amplification with 45 cycles of 95°C for 10 sec, and 60°C for 60 sec with acquisition of fluorescence at the end of each cycle. The threshold cycle (C T ) value for each sample was calculated by the MXPRO qPCR software (Agilent Technologies), with the machine programmed to automatically determine the threshold at each run using its "Amplification-based threshold determination algorithm". Each reaction plate contained several negative controls (no template and negative process control), a calibration curve consisting of plasmid DNA containing the target PCR sequence (see below) in experimental triplicates, and clinical samples in singlet reactions. The standard curve was created automatically with the MxPro qPCR software (Agilent Technologies) plotting C T values against each standard of known concentration. This C T value was also used for calculation of the intra-and inter-assay co-efficients of variation for this technique.
Preparation of standard
The gene copy number was standardized using a plasmid construct containing the partial sequence for Lactobacillus rhamnosus 16S-23S ribosomal RNA (rRNA) intergenic spacer region and its flanking 23S rRNA. This particular sequence was used because it bears 100% sequence match to the published primers and probe used for the real-time PCR assay. Briefly, "multiplex PCR-G" primers (13) were used to amplify a 400-bp PCR product directly from a bacterial culture of L. rhamnosus. The PCR amplicon was gelpurified (A9282; Promega, Madison, WI, USA) and cloned into pGEM â -T Easy Vector (A1360; Promega) according to the manufacturer's instructions. The plasmid was transformed in JM109 competent cells (P9751; Promega) and streaked to obtain a single bacterial colony that was picked and grown in 5 mL of Luria-Bertani broth containing 100 lg/mL ampicillin. Plasmid was extracted using an Aurum plasmid miniprep kit (732-6400, Promega) and the inserted 400-bp sequence identity was verified against an L. rhamnosus intergenic spacer region sequence obtained from GenBank (Accession number AF182730) by standard Sanger sequencing (Ramaciotti Centre, UNSW). Plasmid was quantified by Nanodrop spectrometer (ND1000, Thermo Scientific) and diluted with nuclease-free water to obtain 0.2 9 10 9 copies/lL. This stock standard was frozen at À80°C in multiple aliquots. For preparation of the standard curve, stock standard was thawed to room temperature and diluted at each PCR run using the same pipettes and dilution method. Serial ten-fold and two-fold dilutions were performed on this standard to obtain 0.2 9 10 7 to 0.5 9 10 1 copies/lL. Five microliters of each diluted standard was used to characterize the linearity, precision, specificity and sensitivity of the TaqMan assay over the reporter range of 1 9 10 7 to 2.5 9 10 1 copies/ reaction.
StatStripXPress detection of Lactobacillus from cultures
The capacity of the handheld StatStripXPress meter and strips to detect lactate produced by Lactobacillus spp. was unknown, therefore the meter and strips were studied by measuring the lactate produced from three different strains of Lactobacillus spp. (see Supplementary material, Table S3 ). The three species, known to exist in the human vagina and intestine, were obtained from the Department of Microbiology, South Eastern Area Laboratory Services at the Prince of Wales Hospital. Briefly, 500 lL of a 2.0 MacFarland density solution of a single species of Lactobacillus was inoculated to 5 mL of broth and incubated aerobically at 37°C on a shaking platform with the orbital speed set at 240 rpm. Lactate concentration (StatStripXPress), pH (Sigma pH test strips 0-14 pH, resolution 1.0 pH unit) and optical density (Biowave S2100 diode array spectrophotometer WPA) of the bacterial cultures were determined at 8, 17 and 24 h post-inoculation.
Statistical analyses
Statistical analysis of hand-held lactate (StatStripXPress) results and Lactobacillus spp. detected by PCR was conducted using STATA (version 13 MP; Statacorp, College Station, TX, USA). The amniotic fluid lactate value was treated as a continuous variable in mmol/L (range 0-24 mmol/L). A logarithmic (base 10) transformation was applied to the PCR count. Paired samples were coded for detection or nondetection of Lactobacillus spp. as a dichotomous variable. Specimens with values above the detection limit of 25 copies per reaction but below 100 copies per reaction could not be accurately quantified but were coded as positive for dichotomous outcome. Parametric (paired t-test), nonparametric (Kruskal-Wallis) and bootstrap median regression analyses were performed. Linear regression was used to examine the associations between amniotic lactate level and log (PCR) value with paired samples with counts >0. Clinical data were matched to the dichotomous Lactobacillus results.
Results
The standard curve was tested in experimental triplicates for each plate and the PCR runs were performed over six different days. The average amplification efficiency was 91.4 AE 2.6% (n = 6). The assay exhibited a 6-log linear range from 1 9 10 7 to 1 9 10 2 , with a lower detection limit of 25 copies/reaction (Figure 1a) . The slope and R 2 values of the calibration curves averaged À3.55 AE 0.07 and 99.8 AE 0.001%, respectively (n = 6) (Figure 1b) . The precision of the assay was evaluated by determining the co-efficient of variation of the C T values for between-runs and within-runs. The mean coefficients of variation for inter-assay (n = 4) and intra-assay (n = 3) was 0.77% (range, 0.36-1.08%) and 1.67% (range, 1.1-3.1%), respectively (see Supplementary material, Tables S1 and S2 ).
Vaginal swabs were tested by the 5 0 -nuclease assay in singlet reactions. All no template control and negative process control wells were negative. The limit of detection of this assay was 25 copies/reaction with an average C T value of 35.53 AE 0.39 across the six PCR runs. A specimen was considered positive if it was less than or equal to the C T value for 25 copies of plasmid for each individual PCR run. Specimens were quantified when the C T values were within the reporter range of 1 9 10 7 to 1 9 10 2 copies per reaction. Of the specimens tested, 48/ 388 appeared above the detection limit; 31/48 within the reporter range from 6.49 9 10 3 to 3.97 9 10 6 copies per specimen. The remaining 17/48 had C T values above the detection limit of 25 copies per reaction but below 100 copies per reaction. These 17 could not be accurately quantified but were coded Lactobacillus spp.-positive for the lowest PCR count in the data set (6.49 9 10
3 ) . The mean and median vaginal amniotic fluid lactate results were not statistically different grouped by the presence or absence of Lactobacillus spp. regardless of the method of analysis; parametric (paired t-test, P = 0.80) and nonparametric (Kruskal-Wallis, P = 0.60), (Table 2, Figure 2 ). Bootstrapped interquartile regression showed regression co-efficient 0.16, 95% CI À0.8 to 1.1 (p = 0.60) (Figure 3 ). Lactobacillus measurement on PCR was not normally distributed with significant right skewing. Mode of labor onset and intrapartum use of antibiotics were not associated with differences in Lactobacillus spp. detection rates (Tables 3 and 4) .
Discussion
The study found no correlation between amniotic fluid lactate collected from the vaginal tract of women in labor and detection of Lactobacillus spp. However, a detection rate of Lactobacillus in 48 of 388 (12%) samples was lower than expected given that the literature describes a predominance of Lactobacillus spp. as a hallmark of health in the female reproductive tract (14) (15) (16) . Consensus on the predominance of Lactobacillus in the vagina has been founded on culture and culture-independent methods of analysis, although there are contradictory data regarding prevalence rates, and specific factors that impact rates of detection such as contraception, catamenial products and physiological elements, due in part to differences in the variety of study methods applied (15) . Nonetheless, studies of pregnant and nonpregnant women have found a prevalence rate of Lactobacillus spp. in the vagina ranging from 71 to 100% although early studies applied culture methods before the application of DNA techniques (14, (17) (18) (19) (20) . Recent vaginal ecological studies using culture-independent methods do not clearly report the prevalence rate of Lactobacillus spp. among women but focus on analyzing microbial colonizing distribution patterns, and report on microbial community states and associations between low levels of Lactobacillus spp., bacterial vaginosis and preterm labor (20) (21) (22) (23) (24) . One study, the first longitudinal study of the human vaginal microbiota in pregnancy, compared vaginal community states between 22 pregnant and 32 nonpregnant women using culture-independent methods and found that 61% of pregnant women (who all gave birth to term infants) had a vaginal bacterial microbiome dominated by Lactobacillus spp. (20) . Another study, using standardized sampling protocols, provided robust evidence that the vaginal bacterial microbiome is uniquely different in pregnancy, with variance of molecular phylogeny (species richness and diversity) across both subsite (mid vagina, posterior fornix and vaginal introitus) and according to gestational age (21) . However, it was not the aim of the Lactobacillus study to identify or determine distribution patterns of different Lactobacillus species, or to measure the effect of different species' capacity for lactate production. We performed a simple pragmatic study, to determine whether lactate-producing organisms in the vagina might confound lactate measurement. We chose Lactobacillus as our target organism, as before this experiment we considered that Lactobacillus would be the most likely lactate-producing organism present in the vagina. The primers and probe for this study were chosen on the basis of being the most comprehensive (covering 22 different species of Lactobacillus) probe-based, quantitative, real-time PCR method published at the time we initiated this experiment.
The Lactobacillus detection rate in this study contrasts significantly with previous research findings, although the method used to detect Lactobacillus spp. through quantitative PCR was found to be sensitive and specific in detecting DNA with a limit of detection of ≥25 copies. A major strength of our study is the relatively large sample size. However, technical and clinical factors may have contributed to the low detection rate of Lactobacillus spp. in swabs. The first technical limitation of the assay may have been that specimens tested were not the same quality as a highly purified target plasmid construct. Second, as we were interested in quantifying the amount of Lactobacillus spp. present in the vagina at the time of the lactate collection, specimens were not subject to culture enrichment or selectivity procedures before DNA extraction. Third, it may be that DNA-based PCR was not the best strategy for a study of this kind, which is focused on the production of a metabolite. A different approach may have been to use culture (non-enrichment), cell-membrane impermeable dye treatment before DNA extraction (such as propidium monoazide) and/or real-time RT-PCR. However, although kinetic measures of Lactobacillus assist in interpreting dynamic change in lactate levels, we believe that quantitative assessment of Lactobacillus at a single time point of lactate sampling represents an appropriate surrogate marker for contaminating Lactobacillus.
Several clinical factors may have contributed to low rates of Lactobacillus spp. detection in this study. Inconsistencies in swab sampling techniques between women and clinicians may have contributed to the low detection rate of Lactobacillus spp. However, we think it unlikely that self-collection vs. clinician collection is a major contributing factor to our low detection rate, as self-sampling is known to show no significant difference in specimen quality and to be as efficient as physician-based sampling in culture-based and molecular testing studies (4, (25) (26) (27) (28) . Women who were induced with prostaglandins were also included in the study cohort. As hormonal regulation of vaginal glycogen content and ability of bacteria to adhere to vaginal epithelium are known factors controlling microbial types and population levels within the vagina (15, 16) , we examined the clinical data to investigate whether induction of labor with prostaglandins affected our rate of detection. We also assessed whether antibiotic use in labor was associated with an altered rate of detection as there is evidence to suggest that antibiotic therapy alters vaginal microflora levels (29, 30) . There is also evidence for the antibacterial properties of amniotic fluid (29, 30) , and that smoking reduces the vaginal Lactobacillus count due to cell lysis from lytic phages (31) . However, analysis of the clinical data revealed that rates of detection were not associated with either mode of labor onset, antibiotic use or smoking, although in this study only five women reported that they smoked during pregnancy.
The unique clinical factor common to samples in this study was that swabs were collected from women in labor, after membranes ruptured. Although there was no difference between groups, the estimated average time between rupture of membranes and the time of first lactate sample and swab collection for women having artificial rupture of membranes was 73 min (SD AE38 min, range 0-15 h) and for women having spontaneous rupture, 16 h (SD AE6 h 55 min, range 0-56 h). We speculated on the lavage-like effect of the amniotic fluid, as there is evidence to show that buffering abolishes vaginal acidity attributable to Lactobacillus spp. (32) . We also noted the findings from a study of persistent unbalanced microbial ecology (dysbiosis), which detected a loss of Lactobacillus and low rates of microbial DNA in samples collected from women with preterm premature rupture of membranes when compared with control women with uncomplicated pregnancies at 29 weeks of gestation. The authors suggested that the depletion of Lactobacillus may be due to the constant leakage of amniotic fluid (33) . However, this comparison may be unfair given that low levels of Lactobacillus are associated with dysbiosis.
Lastly, sampling of lactate from free-flowing amniotic fluid in the vagina, as opposed to intra-uterine sampling using an intrauterine catheter, may have contributed to inconsistent lactate results due to the presence of confounding substances that may be found in the reproductive tract of women in labor. The potential for confounding agents has previously been noted in some publications (2, 3, 9) . Aware of the potential limitations of hand-held lactate meters to measure lactate in amniotic fluid, the StatXPress meter has been formally validated to measure lactate in amniotic fluid (10) . The StatXPress validation study found minimal variation between laboratory and point of care methods to measure lactate in amniotic fluid. A small study to assess common labor contaminants (blood, meconium, lubricating jelly and obstetric cream) found lactate levels increased in the presence of whole blood and decreased in the presence of other contaminants as the ratio of contaminant to amniotic fluid increased (9) . However, we believe any inconsistencies in lactate results are an unlikely source of error in this study and find that it is the low rate of Lactobacillus detection that is unexpected. The results of our study are novel and require further investigation.
Conclusion
This study demonstrated no association between either the presence or level of vaginal Lactobacillus spp. and the measurement of amniotic fluid lactate collected from the vaginal tract of women in labor. Our study is the first study to measure the presence of Lactobacillus spp. using molecular techniques, in a cohort of women in labor, after membranes ruptured. The results are an important finding for amniotic fluid lactate research in the development of a noninvasive diagnostic method to assess amniotic fluid lactate levels in the vaginal tract of women during labor.
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